Effect of Acorus calamus L. Polysaccharide on CD274 and CD326 Expression by Lewis Lung Carcinoma Cells in Mice

K A Lopatina1,2, E A Safonova3, K V Nevskaya4

  • 1Laboratory of Oncopharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Tomsk, Russia. k.lopatina@pharmso.ru.

Insights

A natural compound from Acorus calamus L. reduced tumor growth and metastasis in Lewis lung carcinoma. This compound decreased tumor cell expression of PD-L1 (CD274) and CD326, key markers in immune evasion and metastasis.

Area of Science:

  • Immunology
  • Oncology
  • Natural Product Chemistry

Background:

  • Tumor cells evade host immunity through immunosuppression, often involving the PD-1/PD-L1 pathway.
  • PD-L1 (CD274) expression on tumor cells inhibits T cell activity.
  • CD326 expression is linked to tumor metastasis development.

Purpose of the Study:

  • To investigate the antitumor effects of a specific polysaccharide from Acorus calamus L.
  • To determine the impact of this compound on tumor growth, metastasis, and key immune evasion markers.

Main Methods:

  • Lewis lung carcinoma was transplanted into experimental models.
  • Mice were treated with an experimental preparation derived from α(1,2)-L-rhamno-α(1,4)-D-galactopyranosyluronan.
  • Flow cytometry was used to analyze the expression of CD274 (PD-L1) and CD326 on tumor cells post-treatment.

Main Results:

  • The Acorus calamus L. preparation significantly reduced tumor node size.
  • A decrease in the number and area of metastases was observed.
  • Flow cytometry confirmed a reduction in tumor cell populations expressing CD274 (PD-L1) and CD326.

Conclusions:

  • The polysaccharide from Acorus calamus L. exhibits significant antitumor properties.
  • The compound's mechanism may involve downregulating PD-L1 and CD326 expression, thereby potentially restoring anti-tumor immunity and inhibiting metastasis.

Related Concept Videos